Whole-Exome Sequencing Identifies Novel and Previously Reported Mutations in a Case of Intravascular B-Cell Lymphoma
- 17 September 2024
- journal article
- letter
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 46 (12) , 890-893
Abstract
No abstract availableFunding Information
- National Cancer Institute (R01CA275071)
This publication has 18 references indexed in Scilit:
- Western variant intravascular large B-cell lymphoma in an Indian manJAAD Case Reports, 2023
- Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune CheckpointsAmerican Journal of Surgical Pathology, 2022
- Recurrent switch 2 domain RAC2 mutations in intravascular large B-cell lymphomaBlood Advances, 2022
- Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphomaBlood, 2021
- Cytogenetic complexity and heterogeneity in intravascular lymphomaJournal of Clinical Pathology, 2020
- Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network reportBlood, 2020
- COSMIC: the Catalogue Of Somatic Mutations In CancerNucleic Acids Research, 2018
- Sustained proliferation in cancer: Mechanisms and novel therapeutic targetsSeminars in Cancer Biology, 2015
- Comprehensive analysis of cancer-associated somatic mutations in class I HLA genesNature Biotechnology, 2015
- Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL)Experimental Hematology, 2009